NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £608,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East of England, London, North East, North West, South East, Yorkshire and the Humber |
| Deadline | 1 Dec 2023 |
| Contract start | 1 Apr 2024 |
| Contract end | 31 Mar 2028 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c |
Awards (6)
This procurement was awarded to 6 suppliers. Values shown are per-award; the notice total is £608,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Baxter Healthcare Ltd shared | £608,000,000 | 11 Mar 2024 | active |
| ITH Pharma shared | £608,000,000 | 11 Mar 2024 | active |
| LloydsPharmacy Clinical Homecare shared | £608,000,000 | 11 Mar 2024 | active |
| Qualasept Ltd t/a Bath ASU shared | £608,000,000 | 11 Mar 2024 | active |
| Quantum Pharmaceutical shared | £608,000,000 | 11 Mar 2024 | active |
| Sciensus Pharma Services Limited shared | £608,000,000 | 11 Mar 2024 | active |
description
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Tender Reference: CM/PHR/22/5686/01
Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
documents
- https://www.contractsfinder.service.gov.uk/Notice/6800212d-7fe3-47d8-9392-f1cdfc1a94e8 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0ec5420e-b92e-4fe9-8efc-bcc690e0912e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/130a52b4-4ca5-4651-86c6-1611863382d6
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/27d3d91a-7a88-4fad-80c7-9d920aa57fca
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/47b36bfd-9e67-4753-a456-404f5d42f318
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/5693440c-e8e0-4a61-9d13-2833ad118a24
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6ab984df-e38a-498b-842f-ed8f4bd9b8be
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/74abb6ba-73a7-4712-935b-f7231583ff7e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/798baffc-c949-4636-ac54-b48b38f7299c
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/94d20fb5-10d9-4a4a-8423-b7fb32c7af8d
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/9830fff0-df3d-4851-a671-4dbeac4eff27
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/a2e24fd9-cb2a-4fd8-9ff6-7562706fa876
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/a9d2cd54-9b11-4839-a96e-7f1d0ea92ba6
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/aa67a82d-8b87-43ec-bcad-a958330c2a32
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ad1ce8b0-3881-416a-9dee-ecd7d9a1f5c2
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/af2b7c49-237e-4206-91ed-81ed5cb5d8e7
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/b501576c-695c-4b34-a6bb-c78ca4614165
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ba731654-60bb-4b70-b3db-ceba33e465df
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c88ee51a-c81d-49d5-884f-5602f08e8ce3
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f2286dd7-58d1-4ae6-a819-bec83fff3cb1
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/fd2c9e98-035a-423f-80dd-1cb3a961e7b6
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 27 Oct 2023 | Tender (tender) | · | 6800212d-7fe3-47d8-9392-f1cdfc1a94e8-692798 |
| 3 Apr 2024 | Award (award) | · | 5b2ed894-865e-46a1-9251-f9f8b92b6a85-737287 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.